Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
about
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1Plasma D-dimer concentration in patients with systemic sclerosis.Vascular Remodelling and Mesenchymal Transition in Systemic SclerosisRaynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and managementThyroid, hemostasis and thrombosis.No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.Systemic sclerosis-associated pulmonary arterial hypertensionSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesCardiovascular involvement in autoimmune diseases.Sexual dysfunction in married women with Systemic SclerosisPulmonary arterial hypertension associated with systemic sclerosis.IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathwayThe right ventricle in scleroderma (2013 Grover Conference Series).Vascular involvement in systemic sclerosis (scleroderma).Systemic sclerosis: a prototypic multisystem fibrotic disorder.Pathogenesis of Systemic Sclerosis.Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.Pulmonary arterial hypertension in connective tissue diseases.Spatial and temporal dynamics of the endothelium.Endothelial biomedicine: its status as an interdisciplinary field, its progress as a basic science, and its translational bench-to-bedside gap.A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patientsMechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.Atherosclerosis in Systemic Sclerosis: a Modern Controversy.The pathogenesis of systemic sclerosis revisited.Biomarkers in systemic sclerosis.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.Update on etiopathogenesis of systemic sclerosis.Vasculopathy in scleroderma.Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis.Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia.Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A.Shock wave therapy for systemic sclerosis.Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis.Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study.Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis
P2860
Q24805363-5D527EDB-0884-4345-A882-42105ABE7C6EQ25257044-4BDB9967-1C83-4CE3-8C5D-E8A666E08091Q26749091-6CFAF44A-8D04-4B49-B9FF-0B10923087B8Q28392431-A52982E2-0B45-4210-A46B-C472ED68217EQ33365293-A90A2F0A-9A35-4FA2-B48C-30A58749DF24Q33427439-342BCCB6-7BF5-46D5-827E-A77C148F94F8Q33950086-3458CCBE-66B0-436D-8BBF-CB9DD10B75BBQ33965825-2C8BA64D-31A4-44C3-A4CB-E4A440C0086DQ34081242-AC886949-B7EB-42E5-B424-BFF21FB71C5BQ34587257-35A70DAF-C714-4881-826F-906CB6A37EF6Q35002423-3D34B734-0142-4083-8950-01D65B5C5466Q35078513-009EC3E0-52CA-4B60-ACEC-22CF3512D503Q35517421-8F2663A8-2CA9-43F5-BF5D-656CB2395148Q35557424-E4822B0F-176F-4987-863C-D6EC8885D976Q35649427-DAE5D0FD-2A2B-4D9C-BA06-48FCDCA9ED6BQ35693212-DC86B93F-947F-42F3-8C51-48DB0C917D6BQ35743365-20A6518A-4F12-49F2-B1A9-0E4C759830E7Q36075852-FFAC0F0C-E431-4244-A594-AD8A4CBD9FABQ36126944-CD141E54-85C4-4106-B73C-5C1741AD65E6Q36314380-1B6CC6D7-A61A-4689-93B0-68CE5B059EF9Q36469043-6985CF38-2627-40E2-981E-D9731116C473Q37224668-9E9810C7-DD37-4330-B5E7-D5D60818E336Q37265009-C1CB29C2-2D40-48D0-A169-88B87B849F37Q37310583-EF6BFF4B-3563-415B-968E-9FDD504E7205Q37668990-67E78F8D-D9E1-4D2B-928E-F426D9A79175Q37678280-4C256787-6D00-470E-BD60-ADBB1D4EB9B6Q37730018-14D926F7-93EC-42F1-A8F3-8E219B4FD5B9Q38042445-6C0C0F8B-86C0-432C-8C10-BD326C6E0367Q38183300-BFA8CA14-D068-4BD6-BC64-F2E31EC350A6Q38543688-88896057-939E-4743-898B-32BF3AA21E26Q39238174-869D8EEF-CA0F-4C93-9C21-9F2C77550AE7Q39966988-9A4B2C13-EF58-48C2-94AC-A066324658FDQ39989167-BEAC7D62-4B15-40E2-B27B-F09D74FCE34FQ41815275-308B2DAF-2673-4B96-B331-876D81823D48Q42492897-D0C3FC18-8379-451A-838B-60CD3853226EQ44687391-A02299D3-D61A-4E9A-A477-36E09B34E950Q46647964-49CB534F-0722-49E3-A974-9BAD8BF34739Q50052795-4AE560C5-565F-48B3-88C3-D63474170D67Q50329525-900C6B3D-A475-4EEF-A674-F1A2B0134170Q56977476-01FEB2AC-3D2E-4A38-AAD1-B16FD331E001
P2860
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Blood coagulation, fibrinolysi ...... unction in systemic sclerosis.
@en
Blood coagulation, fibrinolysi ...... unction in systemic sclerosis.
@nl
type
label
Blood coagulation, fibrinolysi ...... unction in systemic sclerosis.
@en
Blood coagulation, fibrinolysi ...... unction in systemic sclerosis.
@nl
prefLabel
Blood coagulation, fibrinolysi ...... unction in systemic sclerosis.
@en
Blood coagulation, fibrinolysi ...... unction in systemic sclerosis.
@nl
P2093
P50
P356
P1476
Blood coagulation, fibrinolysi ...... function in systemic sclerosis
@en
P2093
A Del Rosso
G G Sorano
S D'Angelo
S Generini
P304
P356
10.1053/SARH.2002.50011
P577
2003-04-01T00:00:00Z